BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Presidio Pharmaceuticals, Inc. Announces the Appointment of H. Daniel Perez, M.D. as President and Chief Executive Officer


10/25/2011 7:12:18 AM

SAN FRANCISCO--(BUSINESS WIRE)-- Presidio Pharmaceuticals, Inc. is pleased to announce that the Company's Board of Directors has appointed Dr. H. Daniel Perez to be its new President and CEO, replacing Dr. Omar Haffar, effective immediately. Dr. Haffar has led the Company's management team over the past five years after co-founding Presidio in 2006.

Dr. Perez is currently a Venture Partner at Bay City Capital and has served as their representative on the Presidio Board of Directors since 2007. He was previously President and CEO of Berlex Biosciences until it was acquired by Bayer in 2006.

Dr. Perez will work closely with the experienced management team and investors at Presidio to continue research and development efforts on the Company's novel small molecule programs directed to patients infected with Hepatitis C Virus (HCV).

ABOUT PRESIDIO

Presidio Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the discovery, in-licensing, development and commercialization of novel therapeutics for hepatitis C virus (HCV). For more information, please visit our website at www.presidiopharma.com.

Contact:

Presidio Pharmaceuticals, Inc.H. Daniel Perez, MD, 415-655-7560nperez@presidiopharma.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES